Ipswich Investment Management’s Guardant Health GH Stock Holding History

Ipswich Investment Management’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-15,018	Closed	-$1.5M	–	198
2021 Q4	$1.5M	Sell	15,018 -810	-5%	-$83.8K	0.35%	80
2021 Q3	$1.98M	Buy	15,828 +180	+1%	+$21.4K	0.51%	62
2021 Q2	$1.94M	Buy	15,648 +617	+4%	+$83K	0.5%	60
2021 Q1	$2.29M	Sell	15,031 -59	-0.4%	-$8.92K	0.65%	52
2020 Q4	$1.95M	Buy	15,090 +525	+4%	+$60.4K	0.58%	55
2020 Q3	$1.63M	Buy	14,565 +315	+2%	+$28.8K	0.52%	58
2020 Q2	$1.16M	Buy	14,250 +130	+0.9%	+$10.5K	0.4%	65
2020 Q1	$983K	Sell	14,120 -1,600	-10%	-$123K	0.39%	64
2019 Q4	$1.23M	Sell	15,720 -1,490	-9%	-$107K	0.36%	67
2019 Q3	$1.1M	Hold	17,210	–	–	0.35%	71
2019 Q2	$1.49M	Buy	+17,210	New	+$1.31M	0.47%	58

Other funds holding GH

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Ipswich Investment Management's GH Position: Q1 2022 in Review

Ipswich Investment Management sold out of Guardant Health (GH) in Q1 2022, closing a stake of 15,018 shares — an estimated $1.5M sold.

Ipswich Investment Management first reported a position in GH in Q2 2019 and held it in 11 quarters. The position peaked at $2.29M in Q1 2021. 356 funds tracked by Wall St. Rank hold GH as of Q1 2022.

Ipswich Investment Management reported no remaining Guardant Health position as of Q1 2022 after selling out during the quarter.
Ipswich Investment Management sold 15,018 Guardant Health shares in Q1 2022, an estimated $1.5M.
Ipswich Investment Management first reported a position in Guardant Health in Q2 2019 and held it in 11 quarters.
Ipswich Investment Management's Guardant Health position peaked at $2.29M in Q1 2021.
356 funds tracked by Wall St. Rank held Guardant Health as of Q1 2022.

Based on Ipswich Investment Management's 13F filing for Q1 2022, filed 12 Apr 2022.